SCHEMBL8686788

SCHEMBL8686788

N#Cc1ccc(Cn2ccc3c(C=O)cccc32)cc1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 3/20 0.55
▸ SNCA P37840 2/20 0.51
▸ NPM1 P06748 1/20 0.50
▸ DHFR P00374 1/20 0.50
▸ SLC2A1 P11166 1/20 0.50
▸ POLB P06746 1/20 0.49
▸ HTT P42858 4/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ CYP11B1 P15538 1/20 0.47
▸ CYP11B2 P19099 1/20 0.47
▸ CNR2 P34972 1/20 0.47
▸ LMNA P02545 2/20 0.46
▸ CYP19A1 P11511 2/20 0.44
▸ KMT2A Q03164 3/20 0.43
▸ MAPT P10636 2/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ GCGR P47871 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8687577 0.87 APP (0.53) APPSNCANPM1HTTALDH1A1
SCHEMBL6192299 0.83 ALDH1A1 (0.51) APPSNCAPOLBHTTALDH1A1
SCHEMBL8394619 0.83 APP (0.63) APPSNCASLC2A1HTTALDH1A1
SCHEMBL3153751 0.83 ALDH1A1 (0.69) APPSNCANPM1POLBHTT
SCHEMBL8685269 0.82 SMN1; SMN2 (0.50) APPSNCAHTTALDH1A1SMN1; SMN2
SCHEMBL31668340 0.82 ALDH1A1 (0.68) APPSNCAPOLBHTTALDH1A1
SCHEMBL8685406 0.80 APP (0.49) APPSNCAPOLBHTTALDH1A1
SCHEMBL13557315 0.79 POLB (0.51) APPSNCAPOLBHTTALDH1A1
SCHEMBL8685588 0.79 GCGR (0.54) APPSNCAHTTALDH1A1SMN1; SMN2
SCHEMBL8810593 0.78 PARP1 (0.57) APPSNCANPM1DHFRSLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811439-A ANTIDIABETIC AGENTS; SIDE EFFECT REDUCTION; ANTILEPEMIC AGENTS SENGA PHARMACEUTICAL LABORATORY INC. (JP) 1998-09-22 — — US disclosed
EP-0780389-A1 Thiazolidinedione derivatives, process for their preparation and pharmaceutical compositions containing them TOBISHI PHARMACEUTICAL CO., LTD. (JP) 1997-06-25 — — EP disclosed
Send feedback